智飞生物
(300122)
| 流通市值：340.71亿 | | | 总市值：576.66亿 |
| 流通股本：14.14亿 | | | 总股本：23.94亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,263,949,292.31 | 5,586,109,730.2 | 2,971,776,140.82 | 6,340,512,228.61 |
| 应收票据及应收账款 | 21,391,675,746.63 | 25,471,988,622.99 | 30,029,039,075.81 | 27,058,579,283.73 |
| 应收账款 | 21,391,675,746.63 | 25,471,988,622.99 | 30,029,039,075.81 | 27,058,579,283.73 |
| 预付款项 | 59,640,771.04 | 55,738,490.03 | 67,945,089.43 | 74,374,260.21 |
| 其他应收款合计 | 10,300,183.84 | 8,016,555.54 | 13,238,634.05 | 7,795,712.3 |
| 存货 | 20,692,520,989.75 | 15,653,351,532.38 | 12,607,174,247.23 | 8,986,023,821.17 |
| 其他流动资产 | 2,973,707.68 | 16.8 | 5,101,223.26 | 9,731,769.74 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 45,458,060,346.55 | 46,812,204,603.24 | 45,731,274,065.9 | 42,514,016,731.06 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 295,000,000 | 295,000,000 | 295,000,000 | 295,000,000 |
| 投资性房地产 | 198,972.23 | 221,305.94 | 243,639.65 | 265,973.36 |
| 固定资产 | 3,621,578,779.29 | 3,701,659,404 | 3,732,344,728.62 | 3,796,404,998.74 |
| 在建工程 | 1,531,016,046.65 | 1,370,397,956.54 | 1,357,922,773.48 | 1,287,248,697.25 |
| 使用权资产 | 30,326,015.33 | 33,503,938.87 | 34,914,277.61 | 37,058,260.96 |
| 无形资产 | 300,647,626.01 | 304,929,457.75 | 311,157,949.19 | 317,684,334.76 |
| 开发支出 | 1,200,224,519.38 | 1,113,317,941.37 | 1,039,736,765.37 | 1,005,160,453.49 |
| 商誉 | 19,279,096.95 | 19,279,096.95 | 19,279,096.95 | 19,279,096.95 |
| 长期待摊费用 | 85,783,111.73 | 86,940,135.57 | 84,098,292.75 | 82,993,203.73 |
| 递延所得税资产 | 812,879,146.91 | 754,599,800.11 | 641,516,862.48 | 569,190,747.4 |
| 其他非流动资产 | 354,580,927.42 | 353,073,304.83 | 321,312,396.87 | 307,887,816.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,251,514,241.9 | 8,032,922,341.93 | 7,837,526,782.97 | 7,718,173,583.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 53,709,574,588.45 | 54,845,126,945.17 | 53,568,800,848.87 | 50,232,190,314.35 |
| 流动负债: | | | | |
| 短期借款 | 8,649,020,971.55 | 3,442,090,361.14 | 4,575,045,826.56 | 2,635,483,275.35 |
| 应付票据及应付账款 | 12,160,670,010.97 | 16,337,998,358.52 | 14,178,630,976.83 | 13,141,940,772.98 |
| 应付账款 | 12,160,670,010.97 | 16,337,998,358.52 | 14,178,630,976.83 | 13,141,940,772.98 |
| 预收款项 | 23,617,012.78 | 28,829,864 | 35,618,177.36 | 114,114,620.21 |
| 合同负债 | 10,075,699.57 | 5,567,854.59 | 5,954,946.5 | 11,306,389.47 |
| 应付职工薪酬 | 55,094,650.61 | 50,930,586.61 | 37,138,100.71 | 216,651,480.79 |
| 应交税费 | 307,522,291.03 | 497,101,620.56 | 1,010,531,370.88 | 1,553,795,514.94 |
| 其他应付款合计 | 364,917,238.26 | 2,228,747,342.84 | 315,664,270.79 | 366,581,892.99 |
| 应付股利 | - | 1,915,031,797.6 | - | - |
| 一年内到期的非流动负债 | 78,118,654.26 | 61,251,375.91 | 53,370,801.9 | 46,613,063.67 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 21,649,036,529.03 | 22,652,517,364.17 | 20,211,954,471.53 | 18,086,487,010.4 |
| 非流动负债: | | | | |
| 长期借款 | 334,507,804.14 | 379,080,866.29 | 385,013,999.85 | 328,080,291.01 |
| 租赁负债 | 18,953,997.75 | 19,078,272.31 | 22,763,404.97 | 25,307,401.72 |
| 递延收益 | 212,065,989.18 | 215,364,750.61 | 227,516,186.53 | 228,273,877.85 |
| 递延所得税负债 | 53,368,486.82 | 53,747,483.59 | 57,757,896.63 | 57,960,920.05 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 618,896,277.89 | 667,271,372.8 | 693,051,487.98 | 639,622,490.63 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 22,267,932,806.92 | 23,319,788,736.97 | 20,905,005,959.51 | 18,726,109,501.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,393,789,747 | 2,393,789,747 | 2,400,000,000 | 2,400,000,000 |
| 资本公积 | - | - | 47,964,774.94 | 47,964,774.94 |
| 减:库存股 | - | - | 300,030,172.13 | - |
| 盈余公积 | 954,144,855.81 | 954,144,855.81 | 1,200,000,000 | 1,200,000,000 |
| 未分配利润 | 28,093,707,178.72 | 28,177,403,605.39 | 29,315,860,286.55 | 27,858,116,038.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 31,441,641,781.53 | 31,525,338,208.2 | 32,663,794,889.36 | 31,506,080,813.32 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 31,441,641,781.53 | 31,525,338,208.2 | 32,663,794,889.36 | 31,506,080,813.32 |
| 负债和股东权益合计 | 53,709,574,588.45 | 54,845,126,945.17 | 53,568,800,848.87 | 50,232,190,314.35 |
| 公告日期 | 2024-10-26 | 2024-08-30 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |